Ultragenyx Pharmaceutical Sales More Than Triple, Pares Losses

MICHAEL KREY
·2 min read
Ultragenyx Pharmaceutical Sales More Than Triple, Pares Losses
Ultragenyx Pharmaceutical Sales More Than Triple, Pares Losses

Ultragenyx Pharmaceutical posted third-quarter results late Tuesday that beat views on the top and bottom lines after RARE stock hit a nearly five-year high, revenue more than triples.